Similar articles for PMID: 22207133

Year	Number of Results
1993	2
1995	1
1996	1
2000	2
2001	2
2002	2
2003	3
2004	2
2005	5
2006	1
2007	6
2008	4
2009	3
2010	4
2011	11
2012	9
2013	8
2014	9
2015	7
2016	4
2017	6
2018	6
2019	8
2020	5
2021	6
2022	1
2023	2
2024	0

1

Sublingual immunization with adenovirus F protein-based vaccines stimulates protective immunity against botulinum neurotoxin A intoxication.

Jun S, Clapp B, Zlotkowska D, Hoyt T, Holderness K, Maddaloni M, Pascual DW. Jun S, et al. Int Immunol. 2012 Feb;24(2):117-28. doi: 10.1093/intimm/dxr106. Epub 2011 Dec 29. Int Immunol. 2012. PMID: 22207133 Free PMC article.

2

Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A.

Maddaloni M, Staats HF, Mierzejewska D, Hoyt T, Robinson A, Callis G, Kozaki S, Kiyono H, McGhee JR, Fujihashi K, Pascual DW. Maddaloni M, et al. J Immunol. 2006 Oct 15;177(8):5524-32. doi: 10.4049/jimmunol.177.8.5524. J Immunol. 2006. PMID: 17015739

3

Adenovirus F protein as a delivery vehicle for botulinum B.

Clapp B, Golden S, Maddaloni M, Staats HF, Pascual DW. Clapp B, et al. BMC Immunol. 2010 Jul 7;11:36. doi: 10.1186/1471-2172-11-36. BMC Immunol. 2010. PMID: 20609248 Free PMC article.

4

Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits.

Staats HF, Fielhauer JR, Thompson AL, Tripp AA, Sobel AE, Maddaloni M, Abraham SN, Pascual DW. Staats HF, et al. PLoS One. 2011 Jan 27;6(1):e16532. doi: 10.1371/journal.pone.0016532. PLoS One. 2011. PMID: 21304600 Free PMC article.

5

A novel neurotoxoid vaccine prevents mucosal botulism.

Kobayashi R, Kohda T, Kataoka K, Ihara H, Kozaki S, Pascual DW, Staats HF, Kiyono H, McGhee JR, Fujihashi K. Kobayashi R, et al. J Immunol. 2005 Feb 15;174(4):2190-5. doi: 10.4049/jimmunol.174.4.2190. J Immunol. 2005. PMID: 15699151

6

Enhancing toxin-based vaccines against botulism.

Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT. Przedpelski A, et al. Vaccine. 2018 Feb 1;36(6):827-832. doi: 10.1016/j.vaccine.2017.12.064. Epub 2018 Jan 4. Vaccine. 2018. PMID: 29307477 Free PMC article.

7

Dual-route targeted vaccine protects efficiently against botulinum neurotoxin A complex.

Sahay B, Colliou N, Zadeh M, Ge Y, Gong M, Owen JL, Valletti M, Jobin C, Mohamadzadeh M. Sahay B, et al. Vaccine. 2018 Jan 2;36(1):155-164. doi: 10.1016/j.vaccine.2017.11.008. Epub 2017 Nov 24. Vaccine. 2018. PMID: 29180028 Free PMC article.

8

Immunization of mice with the non-toxic HC50 domain of botulinum neurotoxin presented by rabies virus particles induces a strong immune response affording protection against high-dose botulinum neurotoxin challenge.

Mustafa W, Al-Saleem FH, Nasser Z, Olson RM, Mattis JA, Simpson LL, Schnell MJ. Mustafa W, et al. Vaccine. 2011 Jun 20;29(28):4638-45. doi: 10.1016/j.vaccine.2011.04.045. Epub 2011 May 5. Vaccine. 2011. PMID: 21549784 Free PMC article.

9

Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.

Chen BY, Zhou G, Li QL, Lu JS, Shi DY, Pang XB, Zhou XW, Yu YZ, Huang PT. Chen BY, et al. Immunol Lett. 2017 Oct;190:118-124. doi: 10.1016/j.imlet.2017.08.004. Epub 2017 Aug 9. Immunol Lett. 2017. PMID: 28802641

10

Enhancing the protective immune response against botulism.

Przedpelski A, Tepp WH, Kroken AR, Fu Z, Kim JJ, Johnson EA, Barbieri JT. Przedpelski A, et al. Infect Immun. 2013 Jul;81(7):2638-44. doi: 10.1128/IAI.00382-13. Epub 2013 May 13. Infect Immun. 2013. PMID: 23670557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year